DAX23.351 +1,3%ESt505.234 +0,7%Top 10 Crypto13,20 -2,8%Dow42.207 +0,1%Nas19.447 -0,5%Bitcoin89.808 +0,2%Euro1,1523 ±0,0%Öl77,32 -1,8%Gold3.369 ±0,0%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
Rheinmetall 703000 NVIDIA 918422 RENK RENK73 Eutelsat Communications A0HGPT BYD A0M4W9 HENSOLDT HAG000 Lufthansa 823212 Tesla A1CX3T Bayer BAY001 Siemens Energy ENER6Y Allianz 840400 Commerzbank CBK100 Mercedes-Benz Group (ex Daimler) 710000 TUI TUAG50 Deutsche Telekom 555750
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
US-Kriegseintritt? Trump will binnen zwei Wochen entscheiden: DAX geht fester ins Wochenende -- Wall Street letztlich uneins -- Eutelsat, NVIDIA, Tesla, thyssenkrupp nucera, Rheinmetall & Co. im Fokus
Top News
Der neue WhatsApp-Channel von finanzen.net ist da - jetzt abonnieren! Der neue WhatsApp-Channel von finanzen.net ist da - jetzt abonnieren!
Die Highlights im TecDAX: Gewinner und Verlierer der KW 25 im Überblick Die Highlights im TecDAX: Gewinner und Verlierer der KW 25 im Überblick
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil
25 € Neukundenbonus + 1 Aktie gratis. Hol Dir jetzt Dein finanzen.net ZERO-Depot!

Quest Diagnostics Aktie

Handeln
Aktien-Sparplan anlegen
155,45 EUR -0,65 EUR -0,42 %
BMN
179,39 USD -0,37 USD -0,21 %
nachbörslich
BTT
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!
JETZT LOSLEGEN
Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handelnSmartphone

Marktkap.17,42 Mrd. EUR

KGV19,69Div. Rendite1,99%
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKN904533

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINUS74834L1008

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolDGX

Quest Diagnostics Aktien News

DatumMeistgelesen
PR NewswireQuest Diagnostics to Develop Multi-cancer Stratification (MCaST) Blood Test Based on MD Anderson Technology
PR NewswireMore Americans Know Their Streaming Platform Passwords by Heart Than Their Cholesterol Score, New Survey Reveals
PR NewswireQuest Diagnostics to Speak at the William Blair 45th Annual Growth Stock Conference
Wer­bungQuest Diagnostics-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero
PR NewswireQuest Diagnostics Declares Quarterly Cash Dividend
PR NewswireOncologists Report Seeing More Advanced Cancers and Say Current Tests Are Not Catching Cancer Recurrence Early Enough, New Quest Diagnostics Report Finds
PR NewswireQuest Diagnostics Reports First Quarter 2025 Financial Results; Reaffirms Revenue and Adjusted Diluted EPS Guidance for Full Year 2025
PR NewswireQuest Diagnostics Launches New AD-Detect™ Blood Test to Aid in Confirming Alzheimer's Disease
PR NewswireQuest Diagnostics to Release First Quarter 2025 Financial Results on April 22, 2025
PR NewswireQuest Diagnostics to Highlight Strategic Priorities to Drive Sustainable Growth and Deliver Long-term Shareholder Value at 2025 Investor Day
PR NewswireQuest Diagnostics to Collaborate with Google Cloud to Streamline Data and Personalize Customer Experiences Using Generative AI
PR NewswireFresenius Medical Care Announces Divestment of Select Laboratory Assets to Quest Diagnostics
PR NewswireQuest Diagnostics to Host Investor Day on March 19, 2025
PR NewswireGRAIL and Quest Diagnostics Provide GRAIL's Galleri® Multi-Cancer Early Detection (MCED) Test Through the Quest Diagnostics Test Ordering System
PR NewswireQuest Diagnostics Named to Fortune's World's Most Admired Companies List for 11th Consecutive Year
PR NewswireQuest Diagnostics Reports Fourth Quarter and Full Year 2024 Financial Results; Provides Guidance for Full Year 2025; Increases Quarterly Dividend 6.7% to $0.80 Per Share
PR NewswireQuest Diagnostics Completes Acquisition of the Outreach Lab Services Business of University Hospitals
PR NewswireQuest Diagnostics Names Adrienne Brott Senior Vice President and Chief Quality and Regulatory Affairs Officer
PR NewswireQuest Diagnostics to Release Fourth Quarter and Full Year 2024 Financial Results on January 30, 2025
PR NewswireQuest Diagnostics to Speak at the 7th Annual Evercore HealthCONx Conference
PR NewswireQuest Diagnostics Launches Health Coaching on questhealth.com to Help Individuals Take Control of Their Health
PR NewswireQuest Diagnostics Declares Quarterly Cash Dividend
PR NewswireQuest Diagnostics Awarded CDC Contracts for H5 Avian Influenza and Oropouche Virus Test Development
PR NewswireQuest Diagnostics Reports Third Quarter 2024 Financial Results; Updates Guidance for Full Year 2024
PR NewswireQuest Diagnostics Completes Acquisition of Lab Assets from OhioHealth
PR NewswireQuest Diagnostics to Release Third Quarter 2024 Financial Results on October 22, 2024
PR NewswireSentara Health Plans and Quest Diagnostics Form Strategic Collaboration to Extend Lab Access in Parts of the Southeast
PR NewswireQuest Diagnostics Completes Acquisition of Select Lab Assets from Allina Health
PR NewswireQuest Diagnostics to Speak at the Morgan Stanley 22nd Annual Global Healthcare Conference
PR NewswireQuest Diagnostics Completes Acquisition of LifeLabs, Enhancing Access to Diagnostic Innovation
PR NewswireQuest Diagnostics Completes Acquisition of LifeLabs, Enhancing Access to Diagnostic Innovation
PR NewswireQuest Diagnostics to Acquire University Hospitals' Outreach Laboratory Services Business
PR Newswirequesthealth.com Introduces 13 New Blood Tests to Identify Micronutrient Deficiencies
PR NewswireQuest Diagnostics Declares Quarterly Cash Dividend
PR NewswirePregnant Women Undertested for STIs, Finds Quest Diagnostics Health Trends® Study of Over 4 Million Pregnancies
PR NewswireQuest Diagnostics Named a "Best Place to Work for Disability Inclusion" for Seventh Straight Year
PR NewswireHaystack Oncology and Université de Montréal's affiliated hospital research centre, the CRCHUM, to Deploy Haystack MRD™ Technology in Research Study for Metastatic Colorectal Cancer
PR NewswireBD, Quest Diagnostics Join Forces to Develop Companion Diagnostics for Cancer, Other Diseases
PR NewswireQuest Diagnostics Reports Second Quarter 2024 Financial Results; Raises Guidance for Full Year 2024
PR NewswireQuest Diagnostics to Acquire Outreach Laboratory Services of OhioHealth
PR NewswireQuest Diagnostics to Acquire LifeLabs from OMERS, Enhancing Diagnostic Services for Canadians

Quest Diagnostics News

Quest Diagnostics News: auf dieser Seite finden Sie alle Quest Diagnostics News und Nachrichten zur Quest Diagnostics Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Quest Diagnostics News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Quest Diagnostics News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.